GILD
Gilead Sciences
$144.81
−$0.84 (−0.58%)Sep 10, 2026
Key metrics
The numbers that frame GILD today
- Market cap
- $179.56B
- P/E (TTM)
- -55.4
- EV / FCF
- 15.7
- Gross margin
- 79.6%
- EV / Sales
- 6.7
- ROIC
- -2.5%
- Div yield
- 2.22%
- Debt / equity
- 2.2
- 52wk Low
- $106.44
- 52wk High
- $155.38
Growth
Revenue and earnings trend for GILD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GILD
Is Gilead Sciences a good buy?
Yes. Gilead Sciences has excellent quality and strong momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Gilead Sciences is selling at a fair price.
What is the market capitalization of GILD?
Gilead Sciences's market capitalization is $179.56B.
What is the P/E ratio for GILD stock?
Gilead Sciences's current P/E ratio is -55.4.
What is the 52-week high for GILD stock?
The 52-week high for Gilead Sciences is $155.38. The current close of $144.81 is 6.8% below that high.
What is the 52-week low for GILD stock?
The 52-week low for Gilead Sciences is $106.44. The current close of $144.81 is 36% above that low.
Does GILD stock pay dividends?
Gilead Sciences pays a dividend. The latest dividend per share in the company data is $3.22, which implies a yield of 2.22% based on the current close.
What is the Debt / Equity ratio for GILD?
Gilead Sciences's Debt / Equity ratio is 2.22.